PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A butyl alcohol fraction of methanolic extract showed antidiabetic and hepatoprotective activities in rat and mouse models [PMID:29196001]
Allium tuberosum-derived nanovesicles (ADNs) ameliorated symptoms of DSS-induced colitis, including reduced intestinal permeability and improved histological appearance [PMID:38953279]
Exosome-like nanoparticles (A-ELNs) significantly decreased LPS-induced nitric oxide (NO) and inflammatory cytokine levels in BV-2 and MG-6 microglial cells [PMID:37390476]
Extracts from the root, leaf, and scape exhibit antimicrobial activity, with the scape extract showing the most pronounced activity at pH 5.0 [PMID:36386646]
Evidence summary
PubMed sources
- 1.PMID: 35806016 (2022) — Biosynthesis and Metabolism of Garlic Odor Compounds in Cultivated Chinese Chives (Allium tuberosum) and Wild Chinese Chives (Allium hookeri). · International journal of molecular sciences
- 2.PMID: 38953279 (2024) — Allium tuberosum-derived nanovesicles with anti-inflammatory properties prevent DSS-induced colitis and modify the gut microbiome. · Food & function
- 3.PMID: 35284432 (2022) — Residue, Dissipation Pattern, and Dietary Risk Assessment of Imidacloprid in Chinese Chives. · Frontiers in nutrition
- 4.PMID: 29196001 (2017) — Allium tuberosum: Antidiabetic and hepatoprotective activities. · Food research international (Ottawa, Ont.)
- 5.PMID: 37538865 (2023)